Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Clinical Neurology,General Neuroscience
Link
http://www.tandfonline.com/doi/pdf/10.1586/14737175.8.7.1079
Reference68 articles.
1. Five-Factor Model of Schizophrenia Initial Validation
2. Atypical antipsychotics for acute agitation
3. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul-de-sac?
4. Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lumateperone for the Treatment of Schizophrenia;The Journal of Clinical Psychiatry;2023-03-06
2. Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?;Frontiers in Psychiatry;2022-01-25
3. Lemborexant for the Treatment of Insomnia;The Journal of Clinical Psychiatry;2021-06-01
4. Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed;Journal of Affective Disorders;2020-06
5. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials;Bipolar Disorders;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3